University of Münster
CRIS@UM
DE | EN

Marc Dorenkamp

Current affiliations

  • Klinik für Kardiologie I

Publications

The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms
Semo, D; Obergassel, J; Dorenkamp, M; Hemling, P; Strutz, J; Hiden, U; Müller, N; Müller, UA; Zulfikar, SA; Godfrey, R; Waltenberger, J; (2023)
In: Journal of Clinical Medicine, 12(4). doi:10.3390/jcm12041356
Research article (journal) | Peer reviewed | Published
Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function
Dorenkamp, M; Nasiry, M; Sem,o D; Koch, S; Löffler, I; Wolf, G; Reinecke, H; Godfrey, R (2023)
In: Cells, 12(3). doi:10.3390/cells12030513
Research article (journal) | Peer reviewed | Published